Literature DB >> 12679712

Kala-Azar (visceral leishmaniasis) and HIV coinfection in Bihar, India: is this combination increasing?

Chandreshwar Prasad Thakur, Shyam Narayan, Alok Ranjan.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12679712     DOI： 10.1097/00126334-200304150-00017

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  8 in total

1.  AIDS in India.

Authors:  S Solomon; S S Solomon; A K Ganesh
Journal:  Postgrad Med J       Date:  2006-09       Impact factor: 2.401

2.  New challenges in the epidemiology and treatment of visceral leishmaniasis in periurban areas.

Authors:  Kathryn M Dupnik; Eliana L Nascimento; Joao F Rodrigues-Neto; Tatjana Keesen; Maria Zélia Fernandes; Iraci Duarte; Selma M B Jeronimo
Journal:  Drug Dev Res       Date:  2011-09       Impact factor: 4.360

3.  Protective Efficacy of Secondary Prophylaxis Against Visceral Leishmaniasis in Human Immunodeficiency Virus Coinfected Patients Over the Past 10 Years in Eastern India.

Authors:  Rama P Goswami; Rudra P Goswami; Ayan Basu; Yogiraj Ray; Mehebubar Rahman; Santanu K Tripathi
Journal:  Am J Trop Med Hyg       Date:  2016-11-22       Impact factor: 2.345

Review 4.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 5.  The lost hope of elimination of Kala-azar (visceral leishmaniasis) by 2010 and cyclic occurrence of its outbreak in India, blame falls on vector control practices or co-infection with human immunodeficiency virus or therapeutic modalities?

Authors:  Mayilsamy Muniaraj
Journal:  Trop Parasitol       Date:  2014-01

6.  Is elimination of kala-azar feasible by 2017?

Authors:  C P Thakur
Journal:  Indian J Med Res       Date:  2016-12       Impact factor: 2.375

7.  Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome).

Authors:  Sakib Burza; Raman Mahajan; Prabhat K Sinha; Johan van Griensven; Krishna Pandey; María Angeles Lima; Marta Gonzalez Sanz; Temmy Sunyoto; Sunil Kumar; Gaurab Mitra; Ranjeet Kumar; Neena Verma; Pradeep Das
Journal:  PLoS Negl Trop Dis       Date:  2014-08-07

8.  Quality of life perceptions amongst patients co-infected with Visceral Leishmaniasis and HIV: A qualitative study from Bihar, India.

Authors:  Mohit Nair; Pragya Kumar; Sanjay Pandey; Shahwar Kazmi; Laura Moreto-Planas; Alok Ranjan; Sakib Burza
Journal:  PLoS One       Date:  2020-02-10       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.